Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × UNKNOWN × Breast Neoplasms × Clear all

Phase

Phase 2 18 Phase 3 6 Phase NA 4 Phase 4 1 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

OTHER 179 INDUSTRY 56 NIH 2 UNKNOWN 1 OTHER_GOV 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Uterine Cervical Neoplasms 1 Philadelphia Chromosome 1 Papillomavirus Infections 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1 Dwarfism 1 Breast Neoplasms 1

Interventions

toripalimab 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05291910 2022-03-23

Inetetamab Combined With Anti-PD-1 Monoclonal Antibody and Albumin-Bound Paclitaxel for HER2+ Metastatic Breast Cancer

ChineseAMS

Phase 4 Unknown

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡